NO20082047L - Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme - Google Patents

Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme

Info

Publication number
NO20082047L
NO20082047L NO20082047A NO20082047A NO20082047L NO 20082047 L NO20082047 L NO 20082047L NO 20082047 A NO20082047 A NO 20082047A NO 20082047 A NO20082047 A NO 20082047A NO 20082047 L NO20082047 L NO 20082047L
Authority
NO
Norway
Prior art keywords
preparation
slow release
release composition
composition
active ingredient
Prior art date
Application number
NO20082047A
Other languages
English (en)
Other versions
NO339720B1 (no
Inventor
Didier Berthoumieu
Pierre Dupinay
Philippe Trannoy
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NO20082047L publication Critical patent/NO20082047L/no
Publication of NO339720B1 publication Critical patent/NO339720B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/285—Arsenic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen vedrører en farmasøytisk eller nutrasøytisk sammensetning for vedvarende frigivelse av en aktiv ingrediens, sammensetningen omfatter minst ett belagt granulat bestående av en partikkel som inneholder den aktive ingrediensen og er belagt med minst to lag omfattende en kombinasjon av eksipienter. Oppfinnelsen vedrører likeledes en fremgangsmåte for fremstilling av sammensetningen.
NO20082047A 2005-12-01 2008-04-29 Sakte frigivende sammensetning, fremgangsmåte for fremstilling derav og anvendelse av samme NO339720B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512189A FR2894143B1 (fr) 2005-12-01 2005-12-01 Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
PCT/FR2006/002577 WO2007063200A1 (fr) 2005-12-01 2006-11-23 Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation

Publications (2)

Publication Number Publication Date
NO20082047L true NO20082047L (no) 2008-04-29
NO339720B1 NO339720B1 (no) 2017-01-23

Family

ID=36968738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082047A NO339720B1 (no) 2005-12-01 2008-04-29 Sakte frigivende sammensetning, fremgangsmåte for fremstilling derav og anvendelse av samme

Country Status (27)

Country Link
US (1) US8834923B2 (no)
EP (1) EP1954251B1 (no)
JP (1) JP5674275B2 (no)
KR (1) KR101332744B1 (no)
CN (1) CN101321520A (no)
AR (1) AR057212A1 (no)
AT (1) ATE548030T1 (no)
AU (1) AU2006319077B2 (no)
BR (1) BRPI0619774B1 (no)
CA (1) CA2632547C (no)
DK (1) DK1954251T3 (no)
ES (1) ES2383760T3 (no)
FR (1) FR2894143B1 (no)
IL (1) IL191758A (no)
MA (1) MA29770B1 (no)
NO (1) NO339720B1 (no)
NZ (1) NZ566783A (no)
PL (1) PL1954251T3 (no)
PT (1) PT1954251E (no)
RS (1) RS52308B (no)
RU (1) RU2414211C2 (no)
SI (1) SI1954251T1 (no)
TN (1) TNSN08152A1 (no)
TW (1) TWI374035B (no)
UA (1) UA93530C2 (no)
WO (1) WO2007063200A1 (no)
ZA (1) ZA200801896B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0613583D0 (en) * 2006-07-05 2006-08-16 Sericol Ltd A printing ink
CN101912049A (zh) * 2010-07-27 2010-12-15 广州市正百饲料科技有限公司 包被微量元素预混料及其制备方法
CN103191078B (zh) * 2012-01-06 2018-01-09 常州善美药物研究开发中心有限公司 一种双膜多药层的高溶解度盐类药物控释片
NL2014348B1 (en) 2015-02-25 2016-10-13 Univ Delft Tech Controlled release from particles encapsulated by molecular layer deposition.
RU2702690C2 (ru) * 2015-08-13 2019-10-09 БИОЛИНГУС АйПи ЛЛСи Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
RU2616264C1 (ru) * 2016-03-28 2017-04-13 Санкт-Петербургское Государственное бюджетное учреждение здравоохранения "Родильный дом N 10" Способ профилактики железодефицитной анемии у несовершеннолетних беременных женщин
RU2623071C1 (ru) * 2016-09-29 2017-06-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Лечебно-профилактический хелатный железосодержащий препарат для сельскохозяйственных животных
CN106344534B (zh) * 2016-09-30 2019-07-19 广西科技大学 硫酸亚铁肠溶滴丸的制备方法
EP3709994B1 (en) * 2017-11-14 2025-09-10 Pizeta Pharma S.P.A. Oral administration form comprising an iron-copper mixture and its use as a food supplement
CN109999058A (zh) * 2019-05-22 2019-07-12 江阴天江药业有限公司 一种胶类中药的烊化方法和产品，以及由该产品制得的固体饮料及其制备方法
US20250319027A1 (en) * 2022-07-01 2025-10-16 Vitakey Inc. Nutraceutical particles

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3622487A1 (de) * 1986-07-02 1988-01-14 Schering Ag Arzneimittel mit verzoegerter wirkstoffabgabe
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
FR2792527B1 (fr) * 1999-04-22 2004-08-13 Ethypharm Lab Prod Ethiques Microgranules de ketoprofene, procede de preparation et compositions pharmaceutiques
DE50008261D1 (de) * 1999-08-31 2004-11-18 Gruenenthal Gmbh Retardierte darreichungsform enthaltend tramadolsaccharinat
CA2388560A1 (en) * 1999-08-31 2001-03-08 Grunenthal Gmbh Sustained-release form of administration containing tramadol saccharinate
AU783656B2 (en) * 1999-09-02 2005-11-24 Nostrum Pharmaceuticals, Inc. Controlled release oral dosage suitable for oral administration
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
EA200201044A1 (ru) * 2000-03-31 2003-04-24 Нюкомед Аустриа Гмбх Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
KR100477874B1 (ko) 2001-04-10 2005-03-22 곽해수 지방산에스터를 이용한 수용성 철분 미세캡슐
JP2005506323A (ja) * 2001-09-05 2005-03-03 ベクトゥラ・リミテッド 経口送達用機能性散剤
WO2003055475A1 (en) 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
US20030190355A1 (en) * 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
CA2495564A1 (en) * 2002-08-15 2005-01-27 Euro-Celtique S.A. Pharmaceutical compositions
US6562378B1 (en) * 2002-08-16 2003-05-13 Tsar Health Private Ltd. Nutritional supplement for adolescents
US7994214B2 (en) * 2003-08-29 2011-08-09 Lifecycle Pharma A/S Solid dispersions comprising tacrolimus

Also Published As

Publication number Publication date
RU2414211C2 (ru) 2011-03-20
NZ566783A (en) 2010-12-24
FR2894143B1 (fr) 2008-05-02
KR101332744B1 (ko) 2013-11-25
ES2383760T3 (es) 2012-06-26
DK1954251T3 (da) 2012-07-02
AR057212A1 (es) 2007-11-21
JP5674275B2 (ja) 2015-02-25
FR2894143A1 (fr) 2007-06-08
CN101321520A (zh) 2008-12-10
MA29770B1 (fr) 2008-09-01
TWI374035B (en) 2012-10-11
EP1954251B1 (fr) 2012-03-07
AU2006319077B2 (en) 2012-03-29
NO339720B1 (no) 2017-01-23
AU2006319077A1 (en) 2007-06-07
CA2632547A1 (fr) 2007-06-07
IL191758A (en) 2014-11-30
KR20080044911A (ko) 2008-05-21
IL191758A0 (en) 2008-12-29
PT1954251E (pt) 2012-06-06
RU2008126728A (ru) 2010-01-10
TNSN08152A1 (fr) 2009-10-30
BRPI0619774A2 (pt) 2011-10-18
JP2009517445A (ja) 2009-04-30
BRPI0619774B1 (pt) 2021-06-01
TW200800303A (en) 2008-01-01
US8834923B2 (en) 2014-09-16
PL1954251T3 (pl) 2012-08-31
US20090162429A1 (en) 2009-06-25
SI1954251T1 (sl) 2012-08-31
ATE548030T1 (de) 2012-03-15
EP1954251A1 (fr) 2008-08-13
RS52308B (sr) 2012-12-31
UA93530C2 (ru) 2011-02-25
CA2632547C (fr) 2014-03-25
ZA200801896B (en) 2009-09-30
WO2007063200A1 (fr) 2007-06-07

Similar Documents

Publication Publication Date Title
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20090295L (no) Substituerte heteroarylderivater
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20083104L (no) Fast preparat
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
NO20073722L (no) Farmasoystiske sammensetniger omfattende bendamustin
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
CL2007003299A1 (es) Compuestos derivados de macrociclos, inhibidores del virus de la hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
NO20064584L (no) Tetrahydropyridoindolderivater
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
NO20075111L (no) Farmasoytisk sammensetning
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
EP2153831A4 (en) ANTIERMÜDUNGSMITTEL AND ORAL COMPOSITION, BOTH WITH ANDROGRAPHOLIDE AS ACTIVE INGREDIENTS
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
CY1109405T1 (el) Στοματο-διασπειρομενα δισκια δομπεριδονης
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
NO20091644L (no) Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine